Looking at platelet levels in inflammatory bowel disease
Part of Digestive system clinical trials.
This study looks at the size and activity of platelets (the cells that help blood clot) in patients with ulcerative colitis or Crohn's disease, to see if they can be used as markers of inflammation. It is a simple blood test study that may help better understand your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have a confirmed diagnosis of ulcerative colitis or Crohn's disease.
- You cannot have any blood cancer or blood disorders.
- You cannot be pregnant.
- You cannot be taking blood thinners or antiplatelet drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether certain blood tests (called inflammatory biomarkers) can help measure how active your inflammatory bowel disease (Crohn's disease or ulcerative colitis) is. It may help doctors better track your condition and guide treatment, without needing invasive procedures.
This study looks for “biomarkers” (lab markers, like substances in blood or tissue) that may predict how Crohn’s disease or ulcerative colitis will go and how patients may respond. It may help doctors choose better monitoring or treatments in the future.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study checks biomarkers (signals in blood and/or stool) in adults with moderate-to-severe ulcerative colitis. It compares patients starting targeted medicines and looks for marker patterns that may reflect how the disease is behaving.
This study looks at how your blood tests (inflammation levels) change after you start or adjust your treatment for ulcerative colitis or Crohn's disease. It also checks how your gut heals by looking at tissue samples from a follow-up colonoscopy.
This study collects blood and tissue samples to better understand how the immune system behaves in people with inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis. It aims to advance research rather than test a specific new treatment, and it also enrolls healthy volunteers for comparison.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.